Koers OncoVista Innovative Therapies, Inc. Other OTC
Aandelen
OVIT
US68232J1051
Biotechnologie & Medisch Onderzoek
Omzet 2013 | - | Omzet 2014 | - | Marktkapitalisatie | 1,3 mln. 1,2 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -1 mln. -922K | Nettowinst (verlies) 2014 | -2 mln. -1,84 mln. | EV/omzet 2013 | - |
Nettoliquiditeiten 2013 | 44,9K 41,39K | Nettoschuld 2014 | 196K 181K | EV/omzet 2014 | - |
K/w-verhouding 2013 |
-0,75
x | K/w-verhouding 2014 |
-0,51
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 74 | 16-08-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 74 | 16-08-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,63 mld. | |
-5,31% | 39,92 mld. | |
+37,18% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. |